ARCOMA vs GETI-B: Side-by-Side Comparison
Compare Arcoma AB (ARCOMA) and Getinge AB ser. B (GETI-B) side by side: market cap SEK 120.19M vs SEK 54.43B, P/E 32.3 vs 23.1. Financials, growth and model signals on Bullrun.
| Metric | ARCOMA | GETI-B |
|---|---|---|
| Company | Arcoma AB | Getinge AB ser. B |
| Country / Exchange | Sweden · ST | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | SEK 120.19M | SEK 54.43B |
| P/E ratio | 32.3 | 23.1 |
| Dividend yield | — | 2.42% |
| Valuation model | 1.4% undervalued | 14.1% undervalued |
| Revenue (latest FY) | — | SEK 34.76B |
| Revenue growth YoY | — | +9.2% |
| Net income | — | SEK 1.65B |
| Gross margin | — | 46.5% |
| Diluted EPS | — | 6.01 |